(en-US) Jarvis, An, Kullgren et Abergel, « Significance of Single Variables in Defining Adequate Animal Models to Assess the Efficacy of New Radionuclide Decorporation Agents: Using the Contamination Dose as an Example », Drug Development Research, vol. 73, no 5, , p. 281–289 (DOI10.1002/ddr.21020, S2CID82740785, lire en ligne)
(en-US) Choi, Furimsky, Swezey et Bunin, « In Vitro Metabolism and Stability of the Actinide Chelating Agent 3,4,3-LI(1,2-HOPO) », Journal of Pharmaceutical Sciences, vol. 104, no 5, , p. 1832–1838 (PMID25727482, PMCID4390475, DOI10.1002/jps.24394)
(en-US) Sturzbecher-Hoehne, Ng Pak Leung, d'Aléo et Kullgren, « 3,4,3-LI(1,2-HOPO): In Vitro Formation of Highly Stable Lanthanide Complexes Translates into Efficacious In Vivo Europium Decorporation », Dalton Transactions, vol. 40, no 33, , p. 8340–6 (PMID21766096, DOI10.1039/c1dt10840a, S2CID33758070, lire en ligne)
(en-US) Abergel, Durbin, Kullgren et Ebbe, « Biomimetic Actinide Chelators: An Update on the Preclinical Development of the Orally Active Hydroxypyridonate Decorporation Agents 3,4,3-LI(1,2-HOPO) and 5-LIO(Me-3,2-HOPO) », Health Phys., vol. 99, no 3, , p. 401–407 (PMID20699704, PMCID2921233, DOI10.1097/HP.0b013e3181c21273)
(en-US) Panyala, Sturzbecher-Hoehne et Abergel, « Identification of process related trace level impurities in the actinide decorporation agent 3,4,3-LI(1,2-HOPO): Nozzle–skimmer fragmentation via ESI LC–QTOFMS », Journal of Pharmaceutical and Biomedical Analysis, vol. 100, , p. 157–166 (PMID25165012, PMCID4179986, DOI10.1016/j.jpba.2014.08.004)
(en-US) An, Kullgren, Jarvis et Abergel, « From early prophylaxis to delayed treatment: Establishing the plutonium decorporation activity window of hydroxypyridinonate chelating agents », Chemico-Biological Interactions, vol. 267, , p. 80–88 (PMID27038878, PMCID5045775, DOI10.1016/j.cbi.2016.03.034)
(en-US) Deblonde, Sturzbecher-Hoehne et Abergel, « Solution Thermodynamic Stability of Complexes Formed with the Octadentate Hydroxypyridinonate Ligand 3,4,3-LI(1,2-HOPO): A Critical Feature for Efficient Chelation of Lanthanide(IV) and Actinide(IV) Ions », Inorganic Chemistry, vol. 52, no 15, , p. 8805–8811 (PMID23855806, PMCID3771511, DOI10.1021/ic4010246)
(en-US) Choi, Furimsky, Swezey et Bunin, « In Vitro Metabolism and Stability of the Actinide Chelating Agent 3,4,3-LI(1,2-HOPO) », Journal of Pharmaceutical Sciences, vol. 104, no 5, , p. 1832–1838 (PMID25727482, PMCID4390475, DOI10.1002/jps.24394)
(en-US) Sturzbecher-Hoehne, Ng Pak Leung, d'Aléo et Kullgren, « 3,4,3-LI(1,2-HOPO): In Vitro Formation of Highly Stable Lanthanide Complexes Translates into Efficacious In Vivo Europium Decorporation », Dalton Transactions, vol. 40, no 33, , p. 8340–6 (PMID21766096, DOI10.1039/c1dt10840a, S2CID33758070, lire en ligne)
(en-US) Abergel, Durbin, Kullgren et Ebbe, « Biomimetic Actinide Chelators: An Update on the Preclinical Development of the Orally Active Hydroxypyridonate Decorporation Agents 3,4,3-LI(1,2-HOPO) and 5-LIO(Me-3,2-HOPO) », Health Phys., vol. 99, no 3, , p. 401–407 (PMID20699704, PMCID2921233, DOI10.1097/HP.0b013e3181c21273)
(en-US) Panyala, Sturzbecher-Hoehne et Abergel, « Identification of process related trace level impurities in the actinide decorporation agent 3,4,3-LI(1,2-HOPO): Nozzle–skimmer fragmentation via ESI LC–QTOFMS », Journal of Pharmaceutical and Biomedical Analysis, vol. 100, , p. 157–166 (PMID25165012, PMCID4179986, DOI10.1016/j.jpba.2014.08.004)
(en-US) An, Kullgren, Jarvis et Abergel, « From early prophylaxis to delayed treatment: Establishing the plutonium decorporation activity window of hydroxypyridinonate chelating agents », Chemico-Biological Interactions, vol. 267, , p. 80–88 (PMID27038878, PMCID5045775, DOI10.1016/j.cbi.2016.03.034)
(en-US) Deblonde, Sturzbecher-Hoehne et Abergel, « Solution Thermodynamic Stability of Complexes Formed with the Octadentate Hydroxypyridinonate Ligand 3,4,3-LI(1,2-HOPO): A Critical Feature for Efficient Chelation of Lanthanide(IV) and Actinide(IV) Ions », Inorganic Chemistry, vol. 52, no 15, , p. 8805–8811 (PMID23855806, PMCID3771511, DOI10.1021/ic4010246)
(en-US) Jarvis, An, Kullgren et Abergel, « Significance of Single Variables in Defining Adequate Animal Models to Assess the Efficacy of New Radionuclide Decorporation Agents: Using the Contamination Dose as an Example », Drug Development Research, vol. 73, no 5, , p. 281–289 (DOI10.1002/ddr.21020, S2CID82740785, lire en ligne)
(en-US) Sturzbecher-Hoehne, Ng Pak Leung, d'Aléo et Kullgren, « 3,4,3-LI(1,2-HOPO): In Vitro Formation of Highly Stable Lanthanide Complexes Translates into Efficacious In Vivo Europium Decorporation », Dalton Transactions, vol. 40, no 33, , p. 8340–6 (PMID21766096, DOI10.1039/c1dt10840a, S2CID33758070, lire en ligne)
(en-US) Sturzbecher-Hoehne, Ng Pak Leung, d'Aléo et Kullgren, « 3,4,3-LI(1,2-HOPO): In Vitro Formation of Highly Stable Lanthanide Complexes Translates into Efficacious In Vivo Europium Decorporation », Dalton Transactions, vol. 40, no 33, , p. 8340–6 (PMID21766096, DOI10.1039/c1dt10840a, S2CID33758070, lire en ligne)
zenodo.org
(en-US) Jarvis, An, Kullgren et Abergel, « Significance of Single Variables in Defining Adequate Animal Models to Assess the Efficacy of New Radionuclide Decorporation Agents: Using the Contamination Dose as an Example », Drug Development Research, vol. 73, no 5, , p. 281–289 (DOI10.1002/ddr.21020, S2CID82740785, lire en ligne)
